Log in
OTCMKTS:LXRP

Lexaria Bioscience Stock Forecast, Price & News

$0.20
+0.00 (+0.51 %)
(As of 10/23/2020 08:28 PM ET)
Add
Compare
Today's Range
$0.19
Now: $0.20
$0.21
50-Day Range
$0.18
MA: $0.25
$0.32
52-Week Range
$0.17
Now: $0.20
$0.76
Volume106,900 shs
Average Volume133,087 shs
Market Capitalization$17.65 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Lexaria Bioscience Corp. is a proprietary drug delivery technology company. Its technology DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The company's technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules, including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a tobacco producer for the development of smokeless, oral-based nicotine products. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Metal mining
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:LXRP
CUSIP52886N208
Phone(250) 765-6424
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$380,000.00

Profitability

Miscellaneous

Market Cap$17.65 million
Next Earnings Date1/13/2021 (Estimated)
OptionableNot Optionable
$0.20
+0.00 (+0.51 %)
(As of 10/23/2020 08:28 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LXRP News and Ratings via Email

Sign-up to receive the latest news and ratings for LXRP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Lexaria Bioscience (OTCMKTS:LXRP) Frequently Asked Questions

How has Lexaria Bioscience's stock been impacted by COVID-19?

Lexaria Bioscience's stock was trading at $0.3101 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, LXRP shares have decreased by 36.5% and is now trading at $0.1970.
View which stocks have been most impacted by COVID-19
.

When is Lexaria Bioscience's next earnings date?

Lexaria Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, January 13th 2021.
View our earnings forecast for Lexaria Bioscience
.

Are investors shorting Lexaria Bioscience?

Lexaria Bioscience saw a drop in short interest during the month of September. As of September 30th, there was short interest totaling 19,200 shares, a drop of 61.4% from the September 15th total of 49,800 shares. Based on an average daily volume of 529,300 shares, the days-to-cover ratio is currently 0.0 days.
View Lexaria Bioscience's Short Interest
.

Who are some of Lexaria Bioscience's key competitors?

What other stocks do shareholders of Lexaria Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lexaria Bioscience investors own include Canopy Growth (CGC), Aurora Cannabis (ACBFF), OrganiGram (OGI), Cronos Group (CRON), Aphria (APHQF), CV Sciences (CVSI), Auxly Cannabis Group (CBWTF), iAnthus Capital (ITHUF), Alibaba Group (BABA) and GW Pharmaceuticals (GWPH).

Who are Lexaria Bioscience's key executives?

Lexaria Bioscience's management team includes the following people:
  • Christopher A. Bunka, Chairman & Chief Executive Officer
  • John Martin Docherty, President & Director
  • Allan Spissinger, Chief Financial Officer, Secretary & Treasurer
  • Ed Ergenzinger, Chief Legal Officer & Senior VP-Innovation

What is Lexaria Bioscience's stock symbol?

Lexaria Bioscience trades on the OTCMKTS under the ticker symbol "LXRP."

How do I buy shares of Lexaria Bioscience?

Shares of LXRP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Lexaria Bioscience's stock price today?

One share of LXRP stock can currently be purchased for approximately $0.20.

How big of a company is Lexaria Bioscience?

Lexaria Bioscience has a market capitalization of $17.65 million and generates $380,000.00 in revenue each year.

What is Lexaria Bioscience's official website?

The official website for Lexaria Bioscience is www.lexariabioscience.com.

How can I contact Lexaria Bioscience?

Lexaria Bioscience's mailing address is 100 - 740 MCCURDY ROAD, KELOWNA A1, V1X 2P7. The oil and gas exploration company can be reached via phone at (250) 765-6424 or via email at [email protected]

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.